vTv Therapeutics (VTVT) Return on Invested Capital (2017 - 2024)

vTv Therapeutics has disclosed Return on Invested Capital across 7 years of filings, most recently posting 0.02% for Q4 2024.

• Return on Invested Capital for Q4 2024 came in at 0.02%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was 0.02% (changed N/A YoY), and the FY2024 annual result was 0.05%, changed N/A from the prior year.
• Return on Invested Capital came in at 0.02% for Q4 2024 at vTv Therapeutics, down from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2022 to a low of 0.36% in Q1 2024.
• The 4-year median for Return on Invested Capital is 0.0% (2021), against an average of 0.02%.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2020 and advanced 3 bps in 2022, its largest moves.
• vTv Therapeutics' Return on Invested Capital stood at 0.0% in 2020, then soared by 231 bps to 0.01% in 2021, then grew by 19 bps to 0.02% in 2022, then sank by 191 bps to 0.02% in 2024.
• The last three Return on Invested Capital figures came in at 0.02% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q2 2024), per Business Quant data.